Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Pirozzi

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Cancer Discovery|November 3, 2020
Hitting Gliomas When They Are Down: Exploiting IDH-Mutant Metabolic VulnerabilitiesChristopher J Pirozzi, Hai Yan
Nature Reviews. Clinical Oncology|June 16, 2021
The implications of IDH mutations for cancer development and therapyChristopher J Pirozzi, Hai Yan
Cancer Cell|May 18, 2013
Releasing the block: setting differentiation free with mutant IDH inhibitorsChristopher J Pirozzi, Zachary J Reitman, Hai Yan
Current Opinion in Neurology|October 18, 2011
Isocitrate dehydrogenase mutations in gliomas: mechanisms, biomarkers and therapeutic targetChangcun Guo, Christopher J Pirozzi, Giselle Y Lopez, et al.
Cell Communication and Signaling : CCS|December 5, 2024
The CCL5/CCR5/SHP2 axis sustains Stat1 phosphorylation and activates NF-κB signaling promoting M1 macrophage polarization and exacerbating chronic prostatic inflammationChen Jin, Fei Zhang, Hailang Luo, et al.
Plos One|March 20, 2024
Gene expression analysis suggests immunosuppressive roles of endolysosomes in glioblastomaMichael A Sun, Haipei Yao, Qing Yang, et al.
Scientific Reports|March 10, 2022
MTAP loss correlates with an immunosuppressive profile in GBM and its substrate MTA stimulates alternative macrophage polarizationLandon J Hansen, Rui Yang, Kristen Roso, et al.
Communications Biology|November 10, 2023
Mining cancer genomes for change-of-metabolic-function mutationsKevin J Tu, Bill H Diplas, Joshua A Regal, et al.
Biomedicines|April 23, 2022
Purine Synthesis Inhibitor L-Alanosine Impairs Mitochondrial Function and Stemness of Brain Tumor Initiating CellsSimranjit X Singh, Rui Yang, Kristen Roso, et al.
Molecular Cancer Research : MCR|September 15, 2021
Epigenetic Regulation of Fanconi Anemia Genes Implicates PRMT5 Blockage as a Strategy for Tumor ChemosensitizationChangzheng Du, Steven W Li, Simranjit X Singh, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Cancer Discovery|November 3, 2020
Hitting Gliomas When They Are Down: Exploiting IDH-Mutant Metabolic VulnerabilitiesChristopher J Pirozzi, Hai Yan
Nature Reviews. Clinical Oncology|June 16, 2021
The implications of IDH mutations for cancer development and therapyChristopher J Pirozzi, Hai Yan
Cancer Cell|May 18, 2013
Releasing the block: setting differentiation free with mutant IDH inhibitorsChristopher J Pirozzi, Zachary J Reitman, Hai Yan
Current Opinion in Neurology|October 18, 2011
Isocitrate dehydrogenase mutations in gliomas: mechanisms, biomarkers and therapeutic targetChangcun Guo, Christopher J Pirozzi, Giselle Y Lopez, et al.
Cell Communication and Signaling : CCS|December 5, 2024
The CCL5/CCR5/SHP2 axis sustains Stat1 phosphorylation and activates NF-κB signaling promoting M1 macrophage polarization and exacerbating chronic prostatic inflammationChen Jin, Fei Zhang, Hailang Luo, et al.
Plos One|March 20, 2024
Gene expression analysis suggests immunosuppressive roles of endolysosomes in glioblastomaMichael A Sun, Haipei Yao, Qing Yang, et al.
Scientific Reports|March 10, 2022
MTAP loss correlates with an immunosuppressive profile in GBM and its substrate MTA stimulates alternative macrophage polarizationLandon J Hansen, Rui Yang, Kristen Roso, et al.
Communications Biology|November 10, 2023
Mining cancer genomes for change-of-metabolic-function mutationsKevin J Tu, Bill H Diplas, Joshua A Regal, et al.
Biomedicines|April 23, 2022
Purine Synthesis Inhibitor L-Alanosine Impairs Mitochondrial Function and Stemness of Brain Tumor Initiating CellsSimranjit X Singh, Rui Yang, Kristen Roso, et al.
Molecular Cancer Research : MCR|September 15, 2021
Epigenetic Regulation of Fanconi Anemia Genes Implicates PRMT5 Blockage as a Strategy for Tumor ChemosensitizationChangzheng Du, Steven W Li, Simranjit X Singh, et al.
Pageof 3